Malin Corporation | MLC - Ebit

Stock Price
7.85
Daily Change
-0.15 -1.88%
Monthly
1.95%
Yearly
-23.04%
Q1 Forecast
7.76

Malin Corporation reported EUR-1.1M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
ALKERMES USD 89.08M 3.9M Sep/2025
Avita Medical AUD -8.66M 1.61M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Eurofins Scientific SE EUR 530.9M 36.9M Jun/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
Lonza CHF 673M 54M Jun/2025
Malin Corporation EUR -1.1M 300K Dec/2024
Moderna USD -260M 557M Sep/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 98.34M 7.58M Sep/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025